OpenAI adds 1 million access rights to DALL-E 2, $15 can create about 460 pictures; Tesla may “solve fully autonomous driving” by the end of this year

90

Factory dynamics

Google suspends all hiring for two weeks

On July 20, Google announced that it would suspend all hiring for two weeks after Google CEO Pichai announced last week that it would slow down its hiring this year.

Prabhakar Raghavan, Google’s senior vice president, said in an email to employees that the hiring suspension will not affect offers already made to applicants, but that Google will not issue any new offers until the hiring suspension ends. Time to review our headcount needs and adjust a new set of priority staffing requests over the next three months.”

According to foreign media reports, Google hired more than 10,000 employees in the second quarter alone, and parent company Alphabet has nearly 164,000 employees. Alphabet is due to report results after the market close on July 26, with consensus forecasts for earnings of $1.30 per share on revenue of $70.25 billion. (The Information)

Tesla may increase the price of FSD beta software to “solve fully autonomous driving” by the end of this year

According to foreign media reports, Tesla plans to increase the price of its brand full self-driving (FSD: Full Self-Drive) beta software. Currently, Tesla vehicles come standard with Autopilot’s driver assistance system, and owners can purchase the FSD feature for an additional $12,000.

Tesla CEO Elon Musk said on July 20 that so far, Tesla has deployed FSD with city navigation for more than 100,000 car owners, which is similar to Musk’s first-quarter earnings report. The numbers given on the conference call are the same, which means that adoption of the FSD feature has not increased since the first quarter.

Tesla has been raising the price of FSDs in recent years, and Musk has previously said FSDs are “insanely cheap.” As of January 2022, Tesla has increased the cost from a one-time payment of $10,000 to $12,000.

Musk has not said whether Tesla will increase the monthly subscription fee, but he said the price increase will happen before Tesla enters a “broad beta.” In addition, Musk also proposed that Tesla will “solve full self-driving” by the end of this year. (TechCrunch)

Baidu 2022 World Congress Releases the First Aerospace Large Model “Aerospace-Baidu·Wenxin Large Model”

On July 21, the 2022 Baidu World Congress was held online. At the meeting, Baidu disclosed another major progress in the field of pre-training large models. Baidu CTO Wang Haifeng and Liu Jizhong, deputy commander of China’s lunar exploration project and director of the National Space Administration’s Lunar Exploration and Aerospace Engineering Center, released the world’s first aerospace large model. ——”Aerospace-Baidu·Wenxin Large Model”.

According to reports, Aerospace-Baidu·Wenxin integrates learning from data and knowledge in the aerospace field, and can intelligently collect, analyze and understand aerospace data, and facilitate technological breakthroughs in deep space intelligent perception, planning and control. In addition to the Aerospace-Baidu·Wenxin large model, Wenxin has released more than 20 large-scale models, including the jointly released Pengcheng-Baidu·Wenxin, State Grid-Baidu·Wenxin and Pudong Development-Baidu·Wenxin.

Wang Haifeng shared the current status of Baidu PaddlePaddle (Baidu’s deep learning platform PaddlePaddle) in the use of herdsmen, farmers, power plant workers and other user groups. At present, PaddlePaddle has gathered 4.77 million developers. According to IDC report data, PaddlePaddle is a stable leader China’s deep learning platform market comprehensive share first.

In addition, a number of the latest AI technology achievements were also displayed at the Baidu World Congress, including the sixth-generation mass-produced unmanned vehicle Apollo RT6, AI digital human Du Xiaoxiao, three major AI life products Xiaodutiantian smart fitness mirror M30, Xiaodutiantian Du voice intelligent alarm clock and small and large screen eye protection learning machine P20, etc. (Baidu)


Frontier of technology

OpenAI adds 1 million new access rights to DALL-E 2, priced at about $15 for 460 images

On July 20th, OpenAI announced expanded access to DALL-E 2, which will give roughly 1 million people on a waitlist in the coming weeks access to the system and full use of the images created. At the same time, the company announced pricing for the beta phase: users can use each month’s free credits to create AI images, and they can buy an additional 115 credits for $15, which can create about 460 images in total.

OpenAI co-founder Sam Altman previously claimed that DALL-E 2 may affect the job market in the art creation industry. Judging from the pricing announced at this stage, this prediction may come true. However, this move is also a big test for OpenAI’s products, and they need to fix serious flaws in the model as soon as possible. (OpenAI)

Google Open Sources Carb on Programming Language, Calling It Next-Generation C++

At the C++ North event in Toronto this week, Google software engineer Chandler Caruth unveiled the experimental Carbon language, which he says will be a replacement for C++. The developers say that version 0.1 of the language will be completed this year, version 0.2 in 2023, and version 1.0 in 2024 or 2025. It is reported that Carbon was originally an internal project of Google, but the development team hopes that more developers will increase the contribution of more than 50% to the project by the end of the year. (9to5Google)


Landing pioneer

AI pharmaceutical company Yulu Qianxing receives angel round financing

According to news on July 21, AI pharmaceutical company Yulu Qianxing has completed the angel round of financing in May this year, and the investor is Hangzhou Shileng Investment Management Co., Ltd. This round of financing is mainly to introduce strategic shareholders and help the company’s business development.

According to public information, Yulu Qianxing was established in November 2021. It is an interdisciplinary technology-driven biomedical company that uses artificial intelligence, quantum mechanics and molecular simulation algorithms as its core technologies to empower new drug research and development through simulation operations.

Zheng Zheng, founder and CEO of Yulu Qianxing, graduated from Peking University with a major in pharmacy and studied for a Ph.D. in chemistry at the University of Florida. He was a senior scientist at QuantumBio in the United States and an assistant researcher at Michigan State University. After returning to China, he is currently a Distinguished Professor of the “Hundred Talents Program” of the School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Deputy Director of the Department of Chemistry, and Doctoral Supervisor.

It is reported that the new fund-raising plan of Yulu Qianxing Company has been launched, which will be mainly used for team building and new innovative drug research and development pipeline layout. (36 krypton)

Bohan Intelligent received tens of millions of yuan in A round of financing

Recently, Bohan Intelligent (formerly “Yitong Technology”), a provider of industrial Internet AI + big data platform solutions, received tens of millions of yuan in Series A financing. This round of financing was led by Zhuoyuan Capital, an investment institution from Tsinghua University. Investment, Yunmu Capital acted as the exclusive financial advisor; the financing funds will be mainly used for the expansion of the R&D team and the construction of the sales team.

According to public information, Bohan Intelligence (formerly “Yitong Technology”) was established in December 2019. Through its self-developed artificial intelligence end-to-end platform, advanced deep learning algorithms and data processing products, it empowers Everbright industry customers to release Data potential to accelerate the implementation of AI products.

Its founder and CEO, Guo Wei, graduated from Tsinghua University and Victoria University in Canada. He used to be the senior director of Microsoft’s US Computer Personal Division. He has contributed more than 30 invention patents to Microsoft during his 19-year tenure, and has won the Microsoft Gold Star Award and Outstanding Contribution Award for many times. , responsible for leading the research and development of Microsoft Xbox, Kinect, Surface Pro 3, Surface Book and other products.

Co-founder and CTO Su Liqiang has worked in Morgan Stanley and JPMorgan Chase for more than 20 years. He was a vice president of JPMorgan Chase in the United States. He is a world-class leading expert in the fields of data processing, operations research and linear programming.

In addition, the company has a number of core members from Microsoft, Morgan Stanley, Nokia, Tencent, Huawei and other companies. (36 krypton)

AI Biotech Fermion Technology received over 100 million yuan in Series B financing

Recently, Guangzhou Fermion Technology Co., Ltd. (hereinafter referred to as “Fermion”), an AI+ new drug research and development company, has completed the B round of financing, with a financing amount exceeding 100 million yuan; this round of financing parties includes iFlytek Ventures, Zhengxuan Capital, Panda Capital and Challenger Ventures continues to follow the investment; the financing funds will be mainly used to promote the company’s core pipeline in clinical phase 1 research and the subsequent effectiveness proof-of-concept (POC), preclinical development of other pipelines, and the company’s AI drug research and development platform and Further upgrade of the team.

Fermion Technology was founded in August 2018 by Deng Daiguo, a computer doctor of Sun Yat-sen University. It is an AI Biotech company. The company focuses on the central nervous system (CNS), autoimmunity and refractory tumors, and is positioned to develop differentiated BIC based on AI technology. /FIC pipeline, namely “Best-in-class” and “First-in-class”. Among them, the Drug Studio AI drug research and development platform independently developed by the company can focus on solving problems such as drug tissue targeting and high selectivity. (Entrepreneurship State)

Leifeng.com

This article is reprinted from: https://www.leiphone.com/category/academic/d8K7up3vahvydPzu.html
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment